Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
Stock
PRAX
PRAX News & Events
-
Add to Watchlist
Trade PRAX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
PRAX News
Xenon Pharmaceuticals Reports Positive Phase 3 X-TOLE2 Study Results
1d ago
Benzinga
Praxis Grants Restricted Stock Units to New Employees
6d ago
Yahoo Finance
Baker Bros. Increases Praxis Stake to 1.94% with $81.38M Purchase
Feb 23 2026
Fool
Baker Bros. Advisors Increases Stake in Praxis Precision Medicines
Feb 23 2026
NASDAQ.COM
Perceptive Advisors Increases Stake in Praxis Precision Medicines
Feb 22 2026
Fool
Perceptive Advisors Acquires 431,432 Shares of Praxis Precision Medicines
Feb 22 2026
Yahoo Finance
Perceptive Advisors Increases Stake in Celcuity
Feb 22 2026
Yahoo Finance
Perceptive Advisors Increases Stake in Praxis Precision Medicines
Feb 22 2026
NASDAQ.COM
Show More News
PRAX Events
No data
PRAX Monitor News
Praxis Submits NDAs for Ulixacaltamide and Relutrigine
Feb 20 2026
Praxis Precision Medicines to Report Q4 and Full Year 2025 Financial Results
Feb 12 2026
Praxis Precision Medicines Inc rises as it crosses above 5-day SMA
Jan 27 2026
Praxis Precision Medicines falls amid sector rotation
Jan 26 2026
Praxis Precision Medicines Appoints Dr. Orrin Devinsky as Head of Clinical Strategy
Jan 16 2026
Praxis Precision Medicines Appoints Dr. Orrin Devinsky as Head of Clinical Strategy
Jan 14 2026
Praxis Precision Medicines Prices $575M Share Offering
Jan 12 2026
Praxis Precision Medicines raises $575 million through share offering
Jan 07 2026
Show More Monitor News
PRAX Earnings Analysis
No Data
People Also Watch
